- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/54 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 307/54
Total number of patents in this class: 314
10-year publication summary
20
|
39
|
20
|
31
|
15
|
26
|
20
|
16
|
12
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Salk Institute for Biological Studies | 436 |
10 |
ADT Pharmaceuticals, LLC | 14 |
8 |
Proteostasis Therapeutics, Inc. | 72 |
7 |
Mitobridge, Inc. | 58 |
6 |
Toyama Chemical Co., Ltd. | 114 |
6 |
Vectus Biosystems Limited | 36 |
6 |
Corteva Agriscience LLC | 2494 |
6 |
Allergan, Inc. | 2600 |
5 |
Archer Daniels Midland Company | 1164 |
5 |
Biotron Limited | 15 |
5 |
The Regents of the University of California | 18943 |
4 |
President and Fellows of Harvard College | 5792 |
4 |
SK Biopharmaceuticals Co., Ltd. | 248 |
4 |
Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
Janssen Pharmaceutica N.V. | 3839 |
3 |
Board of Regents, The University of Texas System | 5370 |
3 |
Okinawa Institute of Science and Technology School Corporation | 142 |
3 |
Rhodia Operations | 1645 |
3 |
Rosalind Franklin University of Medicine and Science | 88 |
3 |
Signum Biosciences, Inc. | 45 |
3 |
Other owners | 216 |